Global Microneedle Flu Vaccine Market Research Report 2026(Status and Outlook)
Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Microneedle Flu Vaccine market size was estimated at USD 1550.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Microneedle Flu Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Microneedle Flu Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Microneedle Flu Vaccine market.
Global Microneedle Flu Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
GC Pharma
Debiotech
NanoPass Technologies
Corium International
Becton Dickinson and Company
FluGen
CosMED Pharmaceuticals
Microdermics and OraSure Technologies
Market Segmentation (by Type)
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
Market Segmentation (by Application)
Influenza A
Influenza B
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Microneedle Flu Vaccine Market
Overview of the regional outlook of the Microneedle Flu Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Microneedle Flu Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Microneedle Flu Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Microneedle Flu Vaccine market size was estimated at USD 1550.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Microneedle Flu Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Microneedle Flu Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Microneedle Flu Vaccine market.
Global Microneedle Flu Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
GC Pharma
Debiotech
NanoPass Technologies
Corium International
Becton Dickinson and Company
FluGen
CosMED Pharmaceuticals
Microdermics and OraSure Technologies
Market Segmentation (by Type)
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
Market Segmentation (by Application)
Influenza A
Influenza B
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Microneedle Flu Vaccine Market
Overview of the regional outlook of the Microneedle Flu Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Microneedle Flu Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Microneedle Flu Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Microneedle Flu Vaccine
1.2 Key Market Segments
1.2.1 Microneedle Flu Vaccine Segment by Type
1.2.2 Microneedle Flu Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MICRONEEDLE FLU VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Microneedle Flu Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Microneedle Flu Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MICRONEEDLE FLU VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Microneedle Flu Vaccine Product Life Cycle
3.3 Global Microneedle Flu Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Microneedle Flu Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Microneedle Flu Vaccine Market Competitive Situation and Trends
3.8.1 Microneedle Flu Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Microneedle Flu Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MICRONEEDLE FLU VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Microneedle Flu Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MICRONEEDLE FLU VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Microneedle Flu Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Microneedle Flu Vaccine Market
5.7 ESG Ratings of Leading Companies
6 MICRONEEDLE FLU VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Microneedle Flu Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Microneedle Flu Vaccine Market Size by Type (2020-2025)
6.4 Global Microneedle Flu Vaccine Price by Type (2020-2025)
7 MICRONEEDLE FLU VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Microneedle Flu Vaccine Market Sales by Application (2020-2025)
7.3 Global Microneedle Flu Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Microneedle Flu Vaccine Sales Growth Rate by Application (2020-2025)
8 MICRONEEDLE FLU VACCINE MARKET SALES BY REGION
8.1 Global Microneedle Flu Vaccine Sales by Region
8.1.1 Global Microneedle Flu Vaccine Sales by Region
8.1.2 Global Microneedle Flu Vaccine Sales Market Share by Region
8.2 Global Microneedle Flu Vaccine Market Size by Region
8.2.1 Global Microneedle Flu Vaccine Market Size by Region
8.2.2 Global Microneedle Flu Vaccine Market Size by Region
8.3 North America
8.3.1 North America Microneedle Flu Vaccine Sales by Country
8.3.2 North America Microneedle Flu Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Microneedle Flu Vaccine Sales by Country
8.4.2 Europe Microneedle Flu Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Microneedle Flu Vaccine Sales by Region
8.5.2 Asia Pacific Microneedle Flu Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Microneedle Flu Vaccine Sales by Country
8.6.2 South America Microneedle Flu Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Microneedle Flu Vaccine Sales by Region
8.7.2 Middle East and Africa Microneedle Flu Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MICRONEEDLE FLU VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Microneedle Flu Vaccine by Region(2020-2025)
9.2 Global Microneedle Flu Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Microneedle Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Microneedle Flu Vaccine Production
9.4.1 North America Microneedle Flu Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Microneedle Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Microneedle Flu Vaccine Production
9.5.1 Europe Microneedle Flu Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Microneedle Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Microneedle Flu Vaccine Production (2020-2025)
9.6.1 Japan Microneedle Flu Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Microneedle Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Microneedle Flu Vaccine Production (2020-2025)
9.7.1 China Microneedle Flu Vaccine Production Growth Rate (2020-2025)
9.7.2 China Microneedle Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Microneedle Flu Vaccine Product Overview
10.1.3 Sanofi Microneedle Flu Vaccine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 GC Pharma
10.2.1 GC Pharma Basic Information
10.2.2 GC Pharma Microneedle Flu Vaccine Product Overview
10.2.3 GC Pharma Microneedle Flu Vaccine Product Market Performance
10.2.4 GC Pharma Business Overview
10.2.5 GC Pharma SWOT Analysis
10.2.6 GC Pharma Recent Developments
10.3 Debiotech
10.3.1 Debiotech Basic Information
10.3.2 Debiotech Microneedle Flu Vaccine Product Overview
10.3.3 Debiotech Microneedle Flu Vaccine Product Market Performance
10.3.4 Debiotech Business Overview
10.3.5 Debiotech SWOT Analysis
10.3.6 Debiotech Recent Developments
10.4 NanoPass Technologies
10.4.1 NanoPass Technologies Basic Information
10.4.2 NanoPass Technologies Microneedle Flu Vaccine Product Overview
10.4.3 NanoPass Technologies Microneedle Flu Vaccine Product Market Performance
10.4.4 NanoPass Technologies Business Overview
10.4.5 NanoPass Technologies Recent Developments
10.5 Corium International
10.5.1 Corium International Basic Information
10.5.2 Corium International Microneedle Flu Vaccine Product Overview
10.5.3 Corium International Microneedle Flu Vaccine Product Market Performance
10.5.4 Corium International Business Overview
10.5.5 Corium International Recent Developments
10.6 Becton Dickinson and Company
10.6.1 Becton Dickinson and Company Basic Information
10.6.2 Becton Dickinson and Company Microneedle Flu Vaccine Product Overview
10.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Product Market Performance
10.6.4 Becton Dickinson and Company Business Overview
10.6.5 Becton Dickinson and Company Recent Developments
10.7 FluGen
10.7.1 FluGen Basic Information
10.7.2 FluGen Microneedle Flu Vaccine Product Overview
10.7.3 FluGen Microneedle Flu Vaccine Product Market Performance
10.7.4 FluGen Business Overview
10.7.5 FluGen Recent Developments
10.8 CosMED Pharmaceuticals
10.8.1 CosMED Pharmaceuticals Basic Information
10.8.2 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Overview
10.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Market Performance
10.8.4 CosMED Pharmaceuticals Business Overview
10.8.5 CosMED Pharmaceuticals Recent Developments
10.9 Microdermics and OraSure Technologies
10.9.1 Microdermics and OraSure Technologies Basic Information
10.9.2 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Overview
10.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Market Performance
10.9.4 Microdermics and OraSure Technologies Business Overview
10.9.5 Microdermics and OraSure Technologies Recent Developments
11 MICRONEEDLE FLU VACCINE MARKET FORECAST BY REGION
11.1 Global Microneedle Flu Vaccine Market Size Forecast
11.2 Global Microneedle Flu Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Microneedle Flu Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Microneedle Flu Vaccine Market Size Forecast by Region
11.2.4 South America Microneedle Flu Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Microneedle Flu Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Microneedle Flu Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Microneedle Flu Vaccine by Type (2026-2035)
12.1.2 Global Microneedle Flu Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Microneedle Flu Vaccine by Type (2026-2035)
12.2 Global Microneedle Flu Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Microneedle Flu Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Microneedle Flu Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Microneedle Flu Vaccine
1.2 Key Market Segments
1.2.1 Microneedle Flu Vaccine Segment by Type
1.2.2 Microneedle Flu Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MICRONEEDLE FLU VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Microneedle Flu Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Microneedle Flu Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MICRONEEDLE FLU VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Microneedle Flu Vaccine Product Life Cycle
3.3 Global Microneedle Flu Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Microneedle Flu Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Microneedle Flu Vaccine Market Competitive Situation and Trends
3.8.1 Microneedle Flu Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Microneedle Flu Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MICRONEEDLE FLU VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Microneedle Flu Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MICRONEEDLE FLU VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Microneedle Flu Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Microneedle Flu Vaccine Market
5.7 ESG Ratings of Leading Companies
6 MICRONEEDLE FLU VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Microneedle Flu Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Microneedle Flu Vaccine Market Size by Type (2020-2025)
6.4 Global Microneedle Flu Vaccine Price by Type (2020-2025)
7 MICRONEEDLE FLU VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Microneedle Flu Vaccine Market Sales by Application (2020-2025)
7.3 Global Microneedle Flu Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Microneedle Flu Vaccine Sales Growth Rate by Application (2020-2025)
8 MICRONEEDLE FLU VACCINE MARKET SALES BY REGION
8.1 Global Microneedle Flu Vaccine Sales by Region
8.1.1 Global Microneedle Flu Vaccine Sales by Region
8.1.2 Global Microneedle Flu Vaccine Sales Market Share by Region
8.2 Global Microneedle Flu Vaccine Market Size by Region
8.2.1 Global Microneedle Flu Vaccine Market Size by Region
8.2.2 Global Microneedle Flu Vaccine Market Size by Region
8.3 North America
8.3.1 North America Microneedle Flu Vaccine Sales by Country
8.3.2 North America Microneedle Flu Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Microneedle Flu Vaccine Sales by Country
8.4.2 Europe Microneedle Flu Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Microneedle Flu Vaccine Sales by Region
8.5.2 Asia Pacific Microneedle Flu Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Microneedle Flu Vaccine Sales by Country
8.6.2 South America Microneedle Flu Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Microneedle Flu Vaccine Sales by Region
8.7.2 Middle East and Africa Microneedle Flu Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MICRONEEDLE FLU VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Microneedle Flu Vaccine by Region(2020-2025)
9.2 Global Microneedle Flu Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Microneedle Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Microneedle Flu Vaccine Production
9.4.1 North America Microneedle Flu Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Microneedle Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Microneedle Flu Vaccine Production
9.5.1 Europe Microneedle Flu Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Microneedle Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Microneedle Flu Vaccine Production (2020-2025)
9.6.1 Japan Microneedle Flu Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Microneedle Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Microneedle Flu Vaccine Production (2020-2025)
9.7.1 China Microneedle Flu Vaccine Production Growth Rate (2020-2025)
9.7.2 China Microneedle Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Microneedle Flu Vaccine Product Overview
10.1.3 Sanofi Microneedle Flu Vaccine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 GC Pharma
10.2.1 GC Pharma Basic Information
10.2.2 GC Pharma Microneedle Flu Vaccine Product Overview
10.2.3 GC Pharma Microneedle Flu Vaccine Product Market Performance
10.2.4 GC Pharma Business Overview
10.2.5 GC Pharma SWOT Analysis
10.2.6 GC Pharma Recent Developments
10.3 Debiotech
10.3.1 Debiotech Basic Information
10.3.2 Debiotech Microneedle Flu Vaccine Product Overview
10.3.3 Debiotech Microneedle Flu Vaccine Product Market Performance
10.3.4 Debiotech Business Overview
10.3.5 Debiotech SWOT Analysis
10.3.6 Debiotech Recent Developments
10.4 NanoPass Technologies
10.4.1 NanoPass Technologies Basic Information
10.4.2 NanoPass Technologies Microneedle Flu Vaccine Product Overview
10.4.3 NanoPass Technologies Microneedle Flu Vaccine Product Market Performance
10.4.4 NanoPass Technologies Business Overview
10.4.5 NanoPass Technologies Recent Developments
10.5 Corium International
10.5.1 Corium International Basic Information
10.5.2 Corium International Microneedle Flu Vaccine Product Overview
10.5.3 Corium International Microneedle Flu Vaccine Product Market Performance
10.5.4 Corium International Business Overview
10.5.5 Corium International Recent Developments
10.6 Becton Dickinson and Company
10.6.1 Becton Dickinson and Company Basic Information
10.6.2 Becton Dickinson and Company Microneedle Flu Vaccine Product Overview
10.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Product Market Performance
10.6.4 Becton Dickinson and Company Business Overview
10.6.5 Becton Dickinson and Company Recent Developments
10.7 FluGen
10.7.1 FluGen Basic Information
10.7.2 FluGen Microneedle Flu Vaccine Product Overview
10.7.3 FluGen Microneedle Flu Vaccine Product Market Performance
10.7.4 FluGen Business Overview
10.7.5 FluGen Recent Developments
10.8 CosMED Pharmaceuticals
10.8.1 CosMED Pharmaceuticals Basic Information
10.8.2 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Overview
10.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Market Performance
10.8.4 CosMED Pharmaceuticals Business Overview
10.8.5 CosMED Pharmaceuticals Recent Developments
10.9 Microdermics and OraSure Technologies
10.9.1 Microdermics and OraSure Technologies Basic Information
10.9.2 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Overview
10.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Market Performance
10.9.4 Microdermics and OraSure Technologies Business Overview
10.9.5 Microdermics and OraSure Technologies Recent Developments
11 MICRONEEDLE FLU VACCINE MARKET FORECAST BY REGION
11.1 Global Microneedle Flu Vaccine Market Size Forecast
11.2 Global Microneedle Flu Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Microneedle Flu Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Microneedle Flu Vaccine Market Size Forecast by Region
11.2.4 South America Microneedle Flu Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Microneedle Flu Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Microneedle Flu Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Microneedle Flu Vaccine by Type (2026-2035)
12.1.2 Global Microneedle Flu Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Microneedle Flu Vaccine by Type (2026-2035)
12.2 Global Microneedle Flu Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Microneedle Flu Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Microneedle Flu Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Microneedle Flu Vaccine Market Size by Type (M USD)
Table 4. Global Microneedle Flu Vaccine Market Size by Application
Table 5. Microneedle Flu Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Microneedle Flu Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Microneedle Flu Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Microneedle Flu Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedle Flu Vaccine as of 2025)
Table 11. Global Market Microneedle Flu Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Microneedle Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Microneedle Flu Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Microneedle Flu Vaccine Sales by Type (K MT)
Table 27. Global Microneedle Flu Vaccine Market Size by Type (M USD)
Table 28. Global Microneedle Flu Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Microneedle Flu Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Microneedle Flu Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Microneedle Flu Vaccine Market Share by Type (2020-2025)
Table 32. Global Microneedle Flu Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Microneedle Flu Vaccine Sales (K MT) by Application
Table 34. Global Microneedle Flu Vaccine Market Size by Application
Table 35. Global Microneedle Flu Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Microneedle Flu Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Microneedle Flu Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Microneedle Flu Vaccine Market Share by Application (2020-2025)
Table 39. Global Microneedle Flu Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Microneedle Flu Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Microneedle Flu Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Microneedle Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Microneedle Flu Vaccine Market Size by Region (2020-2025)
Table 44. North America Microneedle Flu Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Microneedle Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Microneedle Flu Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Microneedle Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Microneedle Flu Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Microneedle Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Microneedle Flu Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Microneedle Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Microneedle Flu Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Microneedle Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Microneedle Flu Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Microneedle Flu Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Microneedle Flu Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Microneedle Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Microneedle Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Microneedle Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Microneedle Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Microneedle Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Microneedle Flu Vaccine Product Overview
Table 64. Sanofi Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. GC Pharma Basic Information
Table 69. GC Pharma Microneedle Flu Vaccine Product Overview
Table 70. GC Pharma Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GC Pharma Business Overview
Table 72. GC Pharma SWOT Analysis
Table 73. GC Pharma Recent Developments
Table 74. Debiotech Basic Information
Table 75. Debiotech Microneedle Flu Vaccine Product Overview
Table 76. Debiotech Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Debiotech Business Overview
Table 78. Debiotech SWOT Analysis
Table 79. Debiotech Recent Developments
Table 80. NanoPass Technologies Basic Information
Table 81. NanoPass Technologies Microneedle Flu Vaccine Product Overview
Table 82. NanoPass Technologies Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. NanoPass Technologies Business Overview
Table 84. NanoPass Technologies Recent Developments
Table 85. Corium International Basic Information
Table 86. Corium International Microneedle Flu Vaccine Product Overview
Table 87. Corium International Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Corium International Business Overview
Table 89. Corium International Recent Developments
Table 90. Becton Dickinson and Company Basic Information
Table 91. Becton Dickinson and Company Microneedle Flu Vaccine Product Overview
Table 92. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Becton Dickinson and Company Business Overview
Table 94. Becton Dickinson and Company Recent Developments
Table 95. FluGen Basic Information
Table 96. FluGen Microneedle Flu Vaccine Product Overview
Table 97. FluGen Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. FluGen Business Overview
Table 99. FluGen Recent Developments
Table 100. CosMED Pharmaceuticals Basic Information
Table 101. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Overview
Table 102. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. CosMED Pharmaceuticals Business Overview
Table 104. CosMED Pharmaceuticals Recent Developments
Table 105. Microdermics and OraSure Technologies Basic Information
Table 106. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Overview
Table 107. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Microdermics and OraSure Technologies Business Overview
Table 109. Microdermics and OraSure Technologies Recent Developments
Table 110. Global Microneedle Flu Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Microneedle Flu Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Microneedle Flu Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Microneedle Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Microneedle Flu Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Microneedle Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Microneedle Flu Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Microneedle Flu Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Microneedle Flu Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Microneedle Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Microneedle Flu Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Microneedle Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Microneedle Flu Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Microneedle Flu Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Microneedle Flu Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Microneedle Flu Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Microneedle Flu Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Microneedle Flu Vaccine Market Size by Type (M USD)
Table 4. Global Microneedle Flu Vaccine Market Size by Application
Table 5. Microneedle Flu Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Microneedle Flu Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Microneedle Flu Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Microneedle Flu Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedle Flu Vaccine as of 2025)
Table 11. Global Market Microneedle Flu Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Microneedle Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Microneedle Flu Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Microneedle Flu Vaccine Sales by Type (K MT)
Table 27. Global Microneedle Flu Vaccine Market Size by Type (M USD)
Table 28. Global Microneedle Flu Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Microneedle Flu Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Microneedle Flu Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Microneedle Flu Vaccine Market Share by Type (2020-2025)
Table 32. Global Microneedle Flu Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Microneedle Flu Vaccine Sales (K MT) by Application
Table 34. Global Microneedle Flu Vaccine Market Size by Application
Table 35. Global Microneedle Flu Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Microneedle Flu Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Microneedle Flu Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Microneedle Flu Vaccine Market Share by Application (2020-2025)
Table 39. Global Microneedle Flu Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Microneedle Flu Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Microneedle Flu Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Microneedle Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Microneedle Flu Vaccine Market Size by Region (2020-2025)
Table 44. North America Microneedle Flu Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Microneedle Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Microneedle Flu Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Microneedle Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Microneedle Flu Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Microneedle Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Microneedle Flu Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Microneedle Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Microneedle Flu Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Microneedle Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Microneedle Flu Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Microneedle Flu Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Microneedle Flu Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Microneedle Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Microneedle Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Microneedle Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Microneedle Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Microneedle Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Microneedle Flu Vaccine Product Overview
Table 64. Sanofi Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. GC Pharma Basic Information
Table 69. GC Pharma Microneedle Flu Vaccine Product Overview
Table 70. GC Pharma Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GC Pharma Business Overview
Table 72. GC Pharma SWOT Analysis
Table 73. GC Pharma Recent Developments
Table 74. Debiotech Basic Information
Table 75. Debiotech Microneedle Flu Vaccine Product Overview
Table 76. Debiotech Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Debiotech Business Overview
Table 78. Debiotech SWOT Analysis
Table 79. Debiotech Recent Developments
Table 80. NanoPass Technologies Basic Information
Table 81. NanoPass Technologies Microneedle Flu Vaccine Product Overview
Table 82. NanoPass Technologies Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. NanoPass Technologies Business Overview
Table 84. NanoPass Technologies Recent Developments
Table 85. Corium International Basic Information
Table 86. Corium International Microneedle Flu Vaccine Product Overview
Table 87. Corium International Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Corium International Business Overview
Table 89. Corium International Recent Developments
Table 90. Becton Dickinson and Company Basic Information
Table 91. Becton Dickinson and Company Microneedle Flu Vaccine Product Overview
Table 92. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Becton Dickinson and Company Business Overview
Table 94. Becton Dickinson and Company Recent Developments
Table 95. FluGen Basic Information
Table 96. FluGen Microneedle Flu Vaccine Product Overview
Table 97. FluGen Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. FluGen Business Overview
Table 99. FluGen Recent Developments
Table 100. CosMED Pharmaceuticals Basic Information
Table 101. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Overview
Table 102. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. CosMED Pharmaceuticals Business Overview
Table 104. CosMED Pharmaceuticals Recent Developments
Table 105. Microdermics and OraSure Technologies Basic Information
Table 106. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Overview
Table 107. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Microdermics and OraSure Technologies Business Overview
Table 109. Microdermics and OraSure Technologies Recent Developments
Table 110. Global Microneedle Flu Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Microneedle Flu Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Microneedle Flu Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Microneedle Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Microneedle Flu Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Microneedle Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Microneedle Flu Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Microneedle Flu Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Microneedle Flu Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Microneedle Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Microneedle Flu Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Microneedle Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Microneedle Flu Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Microneedle Flu Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Microneedle Flu Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Microneedle Flu Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Microneedle Flu Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Microneedle Flu Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Microneedle Flu Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Microneedle Flu Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Microneedle Flu Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Microneedle Flu Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Microneedle Flu Vaccine Product Life Cycle
Figure 13. Microneedle Flu Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Microneedle Flu Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Microneedle Flu Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Microneedle Flu Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Microneedle Flu Vaccine
Figure 19. Global Microneedle Flu Vaccine Market PEST Analysis
Figure 20. Global Microneedle Flu Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Microneedle Flu Vaccine Market Share by Type
Figure 27. Sales Market Share of Microneedle Flu Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Microneedle Flu Vaccine by Type in 2025
Figure 29. Market Share of Microneedle Flu Vaccine by Type (2020-2025)
Figure 30. Market Share of Microneedle Flu Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Microneedle Flu Vaccine Market Share by Application
Figure 33. Global Microneedle Flu Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Microneedle Flu Vaccine Sales Market Share by Application in 2025
Figure 35. Global Microneedle Flu Vaccine Market Share by Application (2020-2025)
Figure 36. Global Microneedle Flu Vaccine Market Share by Application in 2025
Figure 37. Global Microneedle Flu Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Microneedle Flu Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Microneedle Flu Vaccine Market Size by Region (2020-2025)
Figure 40. North America Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Microneedle Flu Vaccine Sales Market Share by Country in 2024
Figure 43. North America Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Microneedle Flu Vaccine Market Size by Country in 2024
Figure 45. U.S. Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Microneedle Flu Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Microneedle Flu Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Microneedle Flu Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Microneedle Flu Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Microneedle Flu Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Microneedle Flu Vaccine Market Size by Country in 2024
Figure 55. Germany Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Microneedle Flu Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Microneedle Flu Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Microneedle Flu Vaccine Market Size by Region in 2024
Figure 68. China Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Microneedle Flu Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Microneedle Flu Vaccine Sales Market Share by Country in 2024
Figure 80. South America Microneedle Flu Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Microneedle Flu Vaccine Market Size by Country in 2024
Figure 82. Brazil Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Microneedle Flu Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Microneedle Flu Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Microneedle Flu Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Microneedle Flu Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Microneedle Flu Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Microneedle Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Microneedle Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Microneedle Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Microneedle Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Microneedle Flu Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Microneedle Flu Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Microneedle Flu Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Microneedle Flu Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Microneedle Flu Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Microneedle Flu Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Microneedle Flu Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Microneedle Flu Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Microneedle Flu Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Microneedle Flu Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Microneedle Flu Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Microneedle Flu Vaccine Product Life Cycle
Figure 13. Microneedle Flu Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Microneedle Flu Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Microneedle Flu Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Microneedle Flu Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Microneedle Flu Vaccine
Figure 19. Global Microneedle Flu Vaccine Market PEST Analysis
Figure 20. Global Microneedle Flu Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Microneedle Flu Vaccine Market Share by Type
Figure 27. Sales Market Share of Microneedle Flu Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Microneedle Flu Vaccine by Type in 2025
Figure 29. Market Share of Microneedle Flu Vaccine by Type (2020-2025)
Figure 30. Market Share of Microneedle Flu Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Microneedle Flu Vaccine Market Share by Application
Figure 33. Global Microneedle Flu Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Microneedle Flu Vaccine Sales Market Share by Application in 2025
Figure 35. Global Microneedle Flu Vaccine Market Share by Application (2020-2025)
Figure 36. Global Microneedle Flu Vaccine Market Share by Application in 2025
Figure 37. Global Microneedle Flu Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Microneedle Flu Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Microneedle Flu Vaccine Market Size by Region (2020-2025)
Figure 40. North America Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Microneedle Flu Vaccine Sales Market Share by Country in 2024
Figure 43. North America Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Microneedle Flu Vaccine Market Size by Country in 2024
Figure 45. U.S. Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Microneedle Flu Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Microneedle Flu Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Microneedle Flu Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Microneedle Flu Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Microneedle Flu Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Microneedle Flu Vaccine Market Size by Country in 2024
Figure 55. Germany Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Microneedle Flu Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Microneedle Flu Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Microneedle Flu Vaccine Market Size by Region in 2024
Figure 68. China Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Microneedle Flu Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Microneedle Flu Vaccine Sales Market Share by Country in 2024
Figure 80. South America Microneedle Flu Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Microneedle Flu Vaccine Market Size by Country in 2024
Figure 82. Brazil Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Microneedle Flu Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Microneedle Flu Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Microneedle Flu Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Microneedle Flu Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Microneedle Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Microneedle Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Microneedle Flu Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Microneedle Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Microneedle Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Microneedle Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Microneedle Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Microneedle Flu Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Microneedle Flu Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Microneedle Flu Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Microneedle Flu Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Microneedle Flu Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Microneedle Flu Vaccine Market Share Forecast by Application (2026-2035)
